LONSURF 6.14 mg/1
trifluridine and tipiracil · TABLET, FILM COATED · Taiho Pharmaceutical Co., Ltd.
LONSURF is a tablet, film coated containing trifluridine and tipiracil at 6.14 mg/1, taken oral. Manufactured by Taiho Pharmaceutical Co., Ltd..
Key Facts
- Brand Name
- LONSURF
- Generic Name
- trifluridine and tipiracil
- NDC Code (Product)
64842-1025- Manufacturer
- Taiho Pharmaceutical Co., Ltd.
- Strength
- 6.14 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA207981
- Drug Class
- Nucleoside Analog Antiviral [EPC]; Nucleoside Metabolic Inhibitor [EPC]
- Marketing Start
- 09/22/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is LONSURF used for?
LONSURF contains trifluridine and tipiracil. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is LONSURF a controlled substance?
LONSURF is not classified as a controlled substance by the DEA.
What is the generic name for LONSURF?
The generic name for LONSURF is trifluridine and tipiracil. There are no other listed brand versions of trifluridine and tipiracil.
What is the NDC code for LONSURF 6.14 mg/1?
The NDC (National Drug Code) for LONSURF 6.14 mg/1 is 64842-1025, listed by Taiho Pharmaceutical Co., Ltd..
Other LONSURF Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)